Virax Biolabs Group Limited (VRAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2023 | 09-2022 | 03-2022 | 03-2021 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 9,353 | 4,570 | 22 | 18 |
| Receivables | 0 | N/A | 0 | 1 |
| Inventories | 0 | N/A | 21 | 21 |
| Other current assets | 281 | 729 | 6 | 0 |
| TOTAL | $9,634 | $5,299 | $49 | $40 |
| Non-Current Assets | ||||
| Other Non-Current Assets | 178 | 0 | 0 | 0 |
| TOTAL | $178 | $N/A | $N/A | $N/A |
| Total Assets | $9,812 | $5,299 | $49 | $40 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 724 | 725 | 1,115 | 497 |
| Other current liabilities | 38 | 27 | 130 | 375 |
| TOTAL | $908 | $1,143 | $1,245 | $871 |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $908 | $1,143 | $1,245 | $871 |
| Shareholders' Equity | ||||
| Common Shares | 2 | 1 | 1 | 0 |
| Retained earnings | -11,794 | -7,781 | -6,337 | -4,628 |
| Other shareholders' equity | 20,696 | 11,936 | 5,139 | 3,796 |
| TOTAL | $8,904 | $4,156 | $-1,197 | $-832 |
| Total Liabilities And Equity | $9,812 | $5,299 | $48 | $39 |